Enhanced Coordinated Specialty Care for Early Psychosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorMclean Hospital
About this trial
The goal of this clinical trial is to compare engagement in treatment in coordinated specialty care (CSC) to five extra care elements (CSC 2.0) in first-episode psychosis. The main question it aims to answer is:
• Does the addition of certain elements of care increase the number of visits in treatment for first-episode psychosis?
Participants will either:
* Receive care as usual (CSC) or * Receive care as usual (CSC) plus five additional care elements (CSC 2.0):
1. Individual peer support 2. Digital outreach 3. Care coordination 4. Multi-family group therapy 5. Cognitive remediation
Researchers will compare the standard of care (CSC) to CSC 2.0 to see if participants receiving CSC 2.0 have more visits to their clinic in their first year.
Eligibility criteria
Qualifiers
McLean Hospital OnTrack (OnTrack Clinic)
Massachusetts General Hospital (FEPP Clinic)
Boston Medical Center (WRAP Clinic)
Cambridge Health Alliance (RISE Clinic)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Care Coordination
- Individual Peer Support
- Digital Outreach
- Cognitive Remediation
- Multi-Family Group Therapy
Treatment groups
350 Participants
are divided into 2 treatment groupsSponsors and collaborators
Mclean Hospital
Lead sponsor
Massachusetts General Hospital
Collaborator
Boston Medical Center
Collaborator
Cambridge Health Alliance
Collaborator
University of Massachusetts, Worcester
Collaborator
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov